Rehydra+ Wellness review

Rehydra's membership price should be read as a contract, rather than a one-month trial. Its page labels each GLP-1 tier valid for six months and noncancelable, with autopay and a card kept on file. At the starter semaglutide rate of $119, six payments total $714; the starter tirzepatide rate of $169 totals $1,014. Those totals describe the minimum commitment at the published tier, not necessarily one upfront charge. Someone still learning whether treatment suits them should compare that obligation with a one-time purchase before choosing the lower advertised monthly rate.

The membership tiers also differ by dose. Semaglutide is $119, $169 or $229 monthly across the three published tiers, while tirzepatide is $169, $289 or $419. Ask what happens to the contract and price if the clinician recommends a different dose during the six months. A plan covering two starting doses should not be budgeted as though it covers every possible dose. The one-time product pages separately show semaglutide from $149 and tirzepatide from $219, but the final price depends on the selected product options and supply length.

The current homepage describes a free initial call, clinician approval and pharmacy delivery, along with recurring memberships and support. That workflow can be convenient, but approval and shipment timing are not guaranteed for every patient. Ask which clinician and pharmacy will handle the specific prescription and who to contact for a clinical question or delivery problem. A definitive current state list was not established from the pages read. Compounded medications are not FDA-approved. Rehydra is most understandable when the buyer decides between a single supply and a six-month obligation before looking at the rate; the noncancelable contract and dose coverage should drive that choice more than convenience perks.